New FDA-proved obesity drugs, ‘Belviq’ and ‘Contrave,’ entered the domestic market
In the domestic obesity treatment market which has been depressed after expulsion of sibutramine, a series of new obesity drugs have attracted attention of the market.
While Ildong Pharmaceutical has regularized marketing of ‘Belviq,’ a FDA-proved obesity treatment of Arena Pharmaceuticals from ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
